切换至 "中华医学电子期刊资源库"

中华普通外科学文献(电子版) ›› 2022, Vol. 16 ›› Issue (06) : 412 -416. doi: 10.3877/cma.j.issn.1674-0793.2022.06.006

论著

超声内镜引导下胆囊穿刺引流治疗低位恶性梗阻性黄疸的动物实验研究
袁殿宝1,(), 翟明慧2, 吴娜1, 高会斌1   
  1. 1. 075000 张家口,河北北方学院附属第一医院消化科
    2. 075000 张家口,河北北方学院附属第一医院肿瘤内科
  • 收稿日期:2022-07-20 出版日期:2022-12-01
  • 通信作者: 袁殿宝
  • 基金资助:
    河北省2020年度医学科学研究课题计划(20200557)

Endoscopic ultrasonography-guided gallbladder drainage in the treatment of low malignant obstructive jaundice: An animal experimental study

Dianbao Yuan1,(), Minghui Zhai2, Na Wu1, Huibin Gao1   

  1. 1. Department of Gastroenterology, the First Affiliated Hospital of Hebei North University, Zhangjiakou 075000, China
    2. Department of Oncology, the First Affiliated Hospital of Hebei North University, Zhangjiakou 075000, China
  • Received:2022-07-20 Published:2022-12-01
  • Corresponding author: Dianbao Yuan
引用本文:

袁殿宝, 翟明慧, 吴娜, 高会斌. 超声内镜引导下胆囊穿刺引流治疗低位恶性梗阻性黄疸的动物实验研究[J/OL]. 中华普通外科学文献(电子版), 2022, 16(06): 412-416.

Dianbao Yuan, Minghui Zhai, Na Wu, Huibin Gao. Endoscopic ultrasonography-guided gallbladder drainage in the treatment of low malignant obstructive jaundice: An animal experimental study[J/OL]. Chinese Archives of General Surgery(Electronic Edition), 2022, 16(06): 412-416.

目的

基于动物实验模型,探讨超声内镜引导下胆囊穿刺引流术(EUS-GBD)在低位恶性梗阻性黄疸(MOJ)姑息治疗中的应用效果。

方法

纳入SPF级小型实验猪24只,均于腹腔镜下建立低位MOJ模型。按照随机数字表法将模型猪分为实验组和对照组,每组12只,实验组给予EUS-GBD治疗方案,对照组给予经皮经肝胆囊穿刺置管引流术(PTGBD)治疗方案。观察两组手术操作成功率、治疗效果、肝功能指标(总胆红素、直接胆红素、天冬氨酸转氨酶和丙氨酸转氨酶)水平变化及术后并发症发生情况。

结果

24只实验猪均成功建立低位MOJ模型。两组首次操作成功率和治疗总有效率差异均无统计学意义。术后7 d,两组肝功能指标水平均较同组术前明显降低(均P<0.05),但组间差异无统计学意义。实验组术后并发症发生率为25.0%(3/12),低于对照组的41.7%(5/12),但组间差异无统计学意义(P=0.667);两组均无出血、穿孔及导管脱落发生。

结论

EUS-GBD治疗低位MOJ操作成功率高,能有效缓解MOJ的梗阻症状,改善肝功能,整体效果不亚于PTGBD。

Objective

To investigate the effect of endoscopic ultrasonography-guided gallbladder drainage (EUS-GBD) in palliative treatment of low malignant obstructive jaundice (MOJ) based on animal experimental model.

Methods

A total of 24 SPF miniature experimental pigs were included, and the low MOJ model was established under laparoscopy. The model pigs were divided into experimental group and control group according to random number table method, with 12 pigs in each group. The experimental group was given EUS-GBD treatment, and the control group was given percutaneous transhepatic gallbladder drainage (PTGBD) treatment. The success rate of operation, therapeutic effect, changes of liver function indexes such as total bilirubin, direct bilirubin, aspartate aminotransferase, alanine aminotransferase, and postoperative morbidity were compared.

Results

The MOJ model was successfully established in 24 experimental pigs. There were no significant differences in the success rate of the first operation and the total effective rate between the two groups. On the 7th day after operation, the levels of liver function indexes in the two groups were significantly lower than those before operation in the same group (both P<0.05), but there was no significant difference between the two groups. The incidence of postoperative complications in the experimental group was 25.0% (3/12), lower than 41.7% (5/12) in the control group, with no significant difference between the two groups (P=0.667). No bleeding, perforation or catheter shedding were observed in both groups.

Conclusion

EUS-GBD has a high success rate in the treatment of low MOJ, which can effectively alleviate the obstructive symptoms of MOJ and improve liver function of patients, and the overall effect is superior to PTGBD.

表1 建模前后各时间点实验猪肝功能指标水平变化(n=24,±s)
表2 两组实验猪治疗效果比较[n(%)]
表3 两组实验猪手术前后肝功能指标水平比较(±s)
[18]
Choi JH, Kim HW, Lee JC, et al. Percutaneous transhepatic versus EUS-guided gallbladder drainage for malignant cystic duct obstruction[J]. Gastrointest Endos, 2017, 85(2): 357-364.
[1]
Romashchenko PN, Maistrenko NA, Kuznetsov AI, et al. Malignant obstructive jaundice: justification of the method of biliary decompression[J]. Ann HPB Surg, 2020, 25(2): 124-136.
[2]
刘丰豪,蒋晓忠,余钰, 等. ERCP与PTCD应用于恶性梗阻性黄疸疗效对比的Meta分析[J]. 中国内镜杂志, 2020, 26(3): 43-51.
[3]
Duan F, Cui L, Bai Y, et al. Comparison of efficacy and complications of endoscopic and percutaneous biliary drainage in malignant obstructive jaundice: A systematic review and meta-analysis[J]. Cancer Imaging, 2017, 17(1): 27.
[4]
曾江潮,隆洪木,许仲平, 等. 两种姑息性引流方式治疗低位恶性梗阻性黄疸的疗效及免疫学变化分析[J]. 检验医学与临床, 2018, 15(12): 1858-1860.
[5]
赵凯越,张凯,王晟, 等. 超声内镜引导下胆囊介入治疗研究进展[J]. 临床军医杂志, 2020, 48(12): 1503-1506.
[6]
龚建平,程瑶. 恶性梗阻性黄疸术前减黄的标准、指征及效果[J]. 中国普外基础与临床杂志, 2018, 25(7): 781-783.
[7]
高建平,李爽,孙震, 等. 术前减黄在中度恶性梗阻性黄疸胰十二指肠切除中的价值[J/CD]. 中华肝脏外科手术学电子杂志, 2021, 10(4): 381-385.
[8]
梁勇,母齐鸣,万波,等. ERCP放置胆道内支架行姑息性胆道引流术治疗低位恶性梗阻性黄疸的临床疗效分析[J]. 肝胆外科杂志, 2019, 27(5): 348-351.
[9]
孙敏志,徐阿曼,袁笑, 等. PTCD与胆肠内引流术治疗恶性梗阻性黄疸的临床分析[J]. 肝胆外科杂志, 2018, 26(3): 191-194.
[10]
潘孜博,王宇宏,孔哲, 等. 低位恶性梗阻性黄疸术前胆道引流方式的选择[J]. 中华肝胆外科杂志, 2020, 26(4): 259-264.
[11]
陆磊,杨建锋,张筱凤. 内镜超声引导下胆囊穿刺引流术的研究进展[J]. 中华消化内镜杂志, 2017, 34(7): 526-529.
[12]
Teoh AY, Perez-Miranda M, Kunda R, et al. Outcomes of an international multicenter registry on EUS-guided gallbladder drainage in patients at high risk for cholecystectomy[J]. Endosc Int Open, 2019, 7(8): E964-E973.
[13]
齐中,邢颖,汪鑫, 等. 恶性梗阻性黄疸的微创减黄治疗[J]. 中国临床医生杂志, 2021, 49(4): 391-393.
[14]
朱宏毅,沈火剑,李奇为, 等. 三种胆道引流手术治疗恶性阻塞性黄疸的疗效分析[J]. 肝胆胰外科杂志, 2018, 30(6): 467-470.
[15]
刘恩硕,张凯,杨飞, 等. 内镜超声引导下胆囊引流术的方法和价值[J]. 中华消化内镜杂志, 2019, 36(9): 636-639.
[16]
Minaga K, Yamashita Y, Ogura T, et al. Clinical efficacy and safety of endoscopic ultrasound-guided gallbladder drainage replacement of percutaneous drainage: A multicenter retrospective study[J]. Dig Endosc, 2019, 31(2): 180-187.
[17]
Luk SW, Irani S, Krishnamoorthi R, et al. Endoscopic ultrasound-guided gallbladder drainage versus percutaneous cholecystostomy for high risk surgical patients with acute cholecystitis: A systematic review and meta-analysis[J]. Endoscopy, 2019, 51(8): 722-732.
[1] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[2] 刘世君, 马杰, 师鲁静. 胃癌完整系膜切除术+标准D2根治术治疗进展期胃癌的近中期随访研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 27-30.
[3] 赵丽霞, 王春霞, 陈一锋, 胡东平, 张维胜, 王涛, 张洪来. 内脏型肥胖对腹腔镜直肠癌根治术后早期并发症的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 35-39.
[4] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[5] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[6] 徐逸男. 不同术式治疗梗阻性左半结直肠癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 72-75.
[7] 王露, 周丽君. 全腹腔镜下远端胃大部切除不同吻合方式对胃癌患者胃功能恢复、并发症发生率的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 92-95.
[8] 康婵娟, 张海涛, 翟静洁. 胰管支架置入术治疗急性胆源性胰腺炎的效果及对患者肝功能、炎症因子水平的影响[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 667-670.
[9] 付成旺, 杨大刚, 王榕, 李福堂. 营养与炎症指标在可切除胰腺癌中的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 704-708.
[10] 许杰, 李亚俊, 冯义文. SOX新辅助化疗后腹腔镜胃癌D2根治术与常规根治术治疗进展期胃癌的近期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 647-650.
[11] 刘柏隆, 周祥福. 女性尿失禁吊带手术并发症处理的经验分享[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 127-127.
[12] 嵇振岭, 陈杰, 唐健雄. 重视复杂腹壁疝手术并发症的预防和处理[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 601-606.
[13] 江志鹏, 钟克力, 陈双. 复杂腹壁疝手术后腹腔高压与腹腔间室综合征的预防和处理[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 612-615.
[14] 关小玲, 周文营, 陈洪平. PTAAR在乙肝相关慢加急性肝衰竭患者短期预后中的预测价值[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 841-845.
[15] 吴警, 吐尔洪江·吐逊, 温浩. 肝切除术前肝功能评估新进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 889-893.
阅读次数
全文


摘要